# Ixazomib Maintenance Study in Patients With AL Amyloidosis

> **NCT03618537** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 17 (actual)

## Conditions studied

- AL Amyloidosis

## Interventions

- **DRUG:** Ixazomib
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT03618537
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-08-02
- **Primary completion:** 2026-08
- **Final completion:** 2026-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03618537

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03618537, "Ixazomib Maintenance Study in Patients With AL Amyloidosis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03618537. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*